Featuring Melody A. Swartz

This event has been canceled; we are sorry for the inconvenience.

Cancer arises from irregular cell growth, but tumors can also grow and metastasize through compromised immune systems. Cancer immunotherapy aims to train the immune system to destroy tumor cells and help it “remember” to attack those cells to prevent relapse. This form of treatment requires ongoing research into changes in immune regulation in different types of cancer.

Scientist Melody A. Swartz will discuss molecular engineering’s contribution to immunotherapy and her own team’s work to translate it to treat tumors.

Contact harperlectures@uchicago.edu or 773.702.7788.

Event Details

7:30 p.m.  Registration and networking
8:00 p.m.  Presentation and discussion
9:00 p.m.  Reception

406 pesos/person
203 pesos/recent graduate (College alumni of the past 10 years and graduate alumni of the past five years)
Free for UChicago graduates from the current academic year
Two complimentary registrations for members of the Chicago, Harper, Phoenix, and Medical and Biological Sciences Alumni Association philanthropic societies

Parking Information

Special valet-only rate: 140 pesos/1–3 hours; 250 pesos/3–24 hours

Featured Faculty


Melody A. Swartz is the William B. Ogden Professor of Molecular Engineering. She studies the lymphatic system and aims to understand, modulate, and exploit the complex roles of lymphatic vessels in immunity and pathophysiology, especially in cancer. The recipient of a MacArthur Fellowship, which recognizes creativity in all endeavors, Swartz has also received a Career Award from the National Science Foundation, an Arnold and Mabel Beckman Young Investigator Award, and the Wenner Prize—Switzerland’s largest prize for cancer research.

Swartz’s lab aims to develop novel immunotherapeutic approaches to cancer, including vaccines that target lymph nodes.